Drugs | Aflibercept | Ranibizumab | Bevacizumab | Dexamethasone | Triamcinolone | Sham/Placebo |
Adverse events | ||||||
IOP increased | 10/104 | 7/124 | 78/252 | 8/125 | 6/235 | |
Cataract | 13/263 | 7/176 | ||||
Neovascular glaucoma | 0/114 | 0/129 | 3/25 | 7/223 | ||
Conjunctival haemorrhage | 9/104 | 16/125 | 13/119 | 3/68 | ||
Vitreous haemorrhage | 0/114 | 9/144 | 13/217 | |||
Eye irritation | 3/104 | 7/68 | ||||
Eye pain | 12/104 | 15/124 | 15/119 | 3/68 | ||
Retinal haemorrhage | 0/114 | 2/74 | ||||
Retinal tear | 0/114 | 0/15 | 2/88 | |||
Iris neovascularisation | 0/114 | 0/124 | 9/119 | 2/74 | ||
Endophthalmitis | 1/114 | 0/74 | ||||
Retinal ischaemia | 1/104 | 1/124 | 6/119 | 3/68 | ||
Iris rubeosis | 0/30 | 5/30 |
IOP, intraocular pressure.